Engineered endolysin-based "Artilysins" to combat multidrug-resistant gram-negative pathogens - Test2 - elhamkhani - TriplyDB

Engineered endolysin-based "Artilysins" to combat multidrug-resistant gram-negative pathogens

Engineered endolysin-based "Artilysins" to combat multidrug-resistant gram-negative pathogens

http://www.wikidata.org/entity/Q28243174

about

Genetically Engineered Phages: a Review of Advances over the Last Decade Bacteriophages as Weapons Against Bacterial Biofilms in the Food Industry Antimicrobial bacteriophage-derived proteins and therapeutic applications A chimeolysin with extended-spectrum streptococcal host range found by an induced lysis-based rapid screening method Bacteriophage-based tools: recent advances and novel applications Beyond Traditional Antimicrobials: A Caenorhabditis elegans Model for Discovery of Novel Anti-infectives Antibacterial Activity of a Novel Peptide-Modified Lysin Against Acinetobacter baumannii and Pseudomonas aeruginosa Bacteriophages and Their Immunological Applications against Infectious Threats.Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options Efficacy of Artilysin Art-175 against Resistant and Persistent Acinetobacter baumannii.'Artilysation' of endolysin λSa2lys strongly improves its enzymatic and antibacterial activity against streptococci.Engineered bacteriophage lysins as novel anti-infectives Antibacterial properties of Acinetobacter baumannii phage Abp1 endolysin (PlyAB1).Novel phage lysin capable of killing the multidrug-resistant gram-negative bacterium Acinetobacter baumannii in a mouse bacteremia model.Diversity in a Polymicrobial Community Revealed by Analysis of Viromes, Endolysins and CRISPR Spacers.Novel Engineered Peptides of a Phage Lysin as Effective Antimicrobials against Multidrug-Resistant Acinetobacter baumannii.Antimicrobial Peptides: An Emerging Category of Therapeutic Agents.Improved lysis efficiency and immunogenicity of Salmonella ghosts mediated by co-expression of λ phage holin-endolysin and ɸX174 gene E.Bacteriophage-encoded virion-associated enzymes to overcome the carbohydrate barriers during the infection process Phage lytic proteins: biotechnological applications beyond clinical antimicrobials.Breaking barriers: expansion of the use of endolysins as novel antibacterials against Gram-negative bacteria.Structural and Enzymatic Characterization of ABgp46, a Novel Phage Endolysin with Broad Anti-Gram-Negative Bacterial Activity.Potential strategies for the eradication of multidrug-resistant Gram-negative bacterial infections.Genetically modified bacteriophages in applied microbiology.Bacteriophages and their derivatives for the treatment and control of food-producing animal infections.Next-generation precision antimicrobials: towards personalized treatment of infectious diseases.Recent advances in therapeutic delivery systems of bacteriophage and bacteriophage-encoded endolysins.Pseudomonas predators: understanding and exploiting phage-host interactions.Phage therapy: An alternative to antibiotics in the age of multi-drug resistance.The N-terminal and central domain of colicin A enables phage lysin to lyse Escherichia coli extracellularly.In vitro gene expression-coupled bacterial cell chip for screening species-specific antimicrobial enzymes.Synthesis of bacteriophage lytic proteins against Streptococcus pneumoniae in the chloroplast of Chlamydomonas reinhardtii.The antibacterial activity of E. coli bacteriophage lysin lysep3 is enhanced by fusing the Bacillus amyloliquefaciens bacteriophage endolysin binding domain D8 to the C-terminal region.Enhancement of the direct antimicrobial activity of Lysep3 against Escherichia coli by inserting cationic peptides into its C terminus.Characterization and genome sequencing of a Citrobacter freundii phage CfP1 harboring a lysin active against multidrug-resistant isolates.In vitro study of the antibacterial effect of the bacteriophage T5 thermostable endolysin on Escherichia coli cells.A Flagellar Glycan-Specific Protein Encoded by Campylobacter Phages Inhibits Host Cell Growth.Modulation of domain-domain interaction and protein function by a charged linker: a case study of mycobacteriophage D29 endolysin.Molecular dissection of phage lysin PlySs2: integrity of the catalytic and cell wall binding domains is essential for its broad lytic activity.DUF3380 Domain from a Salmonella Phage Endolysin Shows Potent N-Acetylmuramidase Activity

P2860

Q26744156-C37A86E2-CB96-4175-BEFB-3C0C601FFC96 Q26745094-4217F6D1-3377-4C75-8D3A-158C06CA040C Q26781115-5427FF46-EDE5-44D4-9218-D2D402674400 Q27304933-CFEE9691-8F40-49AB-8BDC-7BFC21B1FBBA Q28066480-23F89999-2AD5-4FB7-B934-08705D19AF2B Q28071846-F183599F-9370-4D8C-9F69-FAC7D7101DE2 Q28603769-F5D223AC-C27B-406B-9C18-707666C58F61 Q30234522-B6DD48E6-7DD1-4606-A692-94F5AED95F40 Q30235064-E24DE4D3-2AC2-4651-9F7D-5A94BB7A3287 Q30761262-F9AEE4F8-39ED-4044-96BD-373DFC87C5F2 Q30825736-63EC4727-E0B0-4575-A433-A9FBBD941357 Q34349552-757AF6F6-DE52-461D-A134-30609872359D Q34762253-616154E0-586F-4118-912A-C7B8010E6B53 Q35168859-446927E0-9112-461C-8F19-8FC871944B93 Q36128097-213C474A-C7E7-423A-AA5E-937AA2F7DD8D Q36887978-F83EAAA3-C842-4A9B-B615-FDDB641E5AAF Q37532896-8815987B-918E-4B5A-8589-38CE42CB0C67 Q37717154-C6101BAF-1B66-40E5-8A8E-620DE8CDA8A5 Q37737552-32C5ED20-3F71-4087-A262-A94D9C00692C Q38325227-CA2013A5-6809-4B81-A69F-D31153233E0A Q38392069-9B061211-178F-4BE1-A9E8-D6EB6EE4DAB9 Q38646502-0B40CFF6-EA73-4F08-88CE-8374E877C370 Q38847017-5BFC8E43-F489-4D4D-AC97-B60178BA1592 Q38870317-8E9F6AA3-9F32-45DD-AA06-8C59B60394F4 Q39029801-B8DF418A-B283-49FC-866E-A071CD17A312 Q39379540-5CF3A106-FF6E-4E8A-87DD-400ACA4755FA Q39386520-0346F29D-7FDE-4DC3-B11A-CABC7AB8750C Q39397651-085B8F17-609B-453D-852C-36C0C051D354 Q40075857-6925F648-D84E-4F11-AD85-7C5F09A6D6B4 Q40125437-D8E47E10-D33F-43B3-829B-4C270885A862 Q40267392-A69EB4FF-BE17-469F-8621-F8D6D5567DDC Q40345802-E759E5A5-621D-409A-9B53-6FCFCCF07715 Q40363693-7BAC2B17-C40A-4FDB-B4E5-B2C1409BB395 Q40413579-202AAC31-3EE4-47FC-8B9F-26E6AF920697 Q40523546-3C8E2068-2D5E-4426-834D-8E74C4B0CAD3 Q40533564-7B6CC32C-E543-48E2-8438-BF485009E933 Q41028980-9C99A1B7-4D3D-4731-9039-B8F4F93F3C80 Q41457354-037FCD2E-C443-49BD-87BA-DE3C7271909C Q41484356-6D6BD19D-73D6-475A-9F1B-13BEA0BDBA3D Q41894598-8321E31A-45FA-48C5-9796-52E3ED54B511

P2860

Engineered endolysin-based "Artilysins" to combat multidrug-resistant gram-negative pathogens

http://www.wikidata.org/entity/Q28243174

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Engineered endolysin-based "Ar ...... istant gram-negative pathogens

@ast

Engineered endolysin-based "Ar ...... istant gram-negative pathogens

@en

Engineered endolysin-based "Ar ...... istant gram-negative pathogens

@nl

type

label

Engineered endolysin-based "Ar ...... istant gram-negative pathogens

@ast

Engineered endolysin-based "Ar ...... istant gram-negative pathogens

@en

Engineered endolysin-based "Ar ...... istant gram-negative pathogens

@nl

prefLabel

Engineered endolysin-based "Ar ...... istant gram-negative pathogens

@ast

Engineered endolysin-based "Ar ...... istant gram-negative pathogens

@en

Engineered endolysin-based "Ar ...... istant gram-negative pathogens

@nl

P1433

Q28243174-B5A04705-58BC-4865-B6C9-E46EB62F5ECF

P1476

Q28243174-3F873B20-2DE8-4AD9-98D1-0BA40F6FF466

P2093

Q28243174-5C36C419-DCF3-4789-96B3-02DB112E3EC5

Q28243174-61C9AB05-D63C-49DD-A489-4E787EF741DB

Q28243174-72FB6363-3952-4F52-BB23-3E778554C397

Q28243174-736A2A1D-55FD-45B8-A5C8-F1ED6F854449

Q28243174-8135B9FB-A67B-4A29-B5A1-1E4AB89C419E

Q28243174-AB82D5EB-B90B-462E-B20A-423990DE991C

Q28243174-FC36AFB0-3307-48B1-B227-F844B11832E9

P2860

Q28243174-0AA96724-D581-42A9-B7EE-8C965E1D376F

Q28243174-0E34868A-30E0-437D-9CEC-F6E42FC3F767

Q28243174-10AF0DC0-169A-4192-9C5D-D902D55671D6

Q28243174-182BF06E-3138-48EB-8DD8-F4CC6B52C859

Q28243174-1B9A1F95-9FE8-4E5F-8F2F-D267BEE84CD4

Q28243174-1D402F48-04F6-4CD0-A5D8-861E655CD6A2

Q28243174-270431F5-FF11-4890-B938-05D308FA4CB8

Q28243174-3514A11F-AA2B-45C7-B27F-CEE55CDB875C

Q28243174-3E4D9ABC-4D03-4124-86B0-9CDDBCB99D73

Q28243174-49EF9C38-9853-4100-8BE4-332C1A5885DE

P304

Q28243174-E76C3C6D-443C-41E7-9E54-DD508CADF0DC

P31

Q28243174-DF10646E-2D71-417B-9B64-50E7268A72C0

P3181

Q28243174-2A3AB75B-B392-4C0B-AAD5-D6D8CE1780A9

P356

Q28243174-2E76BCF8-B14E-4BCB-8523-EFD37A0D5F39

P407

Q28243174-6719FA32-4D2D-40DE-B5B4-87EC2ABE347A

P433

Q28243174-266EFEE7-BE70-4A61-91AB-E8606F72DF0D

P478

Q28243174-ED659494-8B54-4F55-B57C-AB089991FE52

P50

Q28243174-28BC47AE-809B-4AE9-85E1-C21C8EE770EB

Q28243174-5474D35A-26C1-4339-98A1-442CC3F60F8C

Q28243174-7B13889D-85BB-46D7-951D-0D3A4F40AD5B

Q28243174-BA259E64-C642-4BD6-B722-246C5AA125ED

Q28243174-D78B8A85-77B3-44EA-ADD8-7CBAA8795FC9

Q28243174-E51DE83A-C269-4D04-8557-1FD4149021C8

P577

Q28243174-29D3774F-40CB-4384-903F-D37B09AC96BD

P5875

Q28243174-C83E6A2A-E7E9-4150-911C-D2AD1E6B1951

P698

Q28243174-BB327DF3-4075-4363-A8A7-BC093EFAB464

P921

Q28243174-B33A32BC-E1D7-4804-B5A9-B7FA21CE8BF5

Q28243174-EEEC0A2D-4612-4177-B558-1CF7BE3AFECC

P932

Q28243174-825EB737-9607-48AD-8A21-BC7955A94B7A

P3181

P356

P1433

P1476

Engineered endolysin-based "Ar ...... istant gram-negative pathogens

@en

P2093

Anneleen Cornelissen

http://www.w3.org/2001/XMLSchema#string

Guido Volckaert

http://www.w3.org/2001/XMLSchema#string

Gunther Verween

http://www.w3.org/2001/XMLSchema#string

Maarten Walmagh

http://www.w3.org/2001/XMLSchema#string

Stefan Miller

http://www.w3.org/2001/XMLSchema#string

William Cenens

http://www.w3.org/2001/XMLSchema#string

Yves Briers

http://www.w3.org/2001/XMLSchema#string

P2860

The genetics of Caenorhabditis elegans

Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme

Lipopolysaccharide endotoxins

Structural engineering of a phage lysin that targets Gram-negative pathogens

Characterization of modular bacteriophage endolysins from Myoviridae phages OBP, 201φ2-1 and PVP-SE1

Killing of Caenorhabditis elegans by Pseudomonas aeruginosa used to model mammalian bacterial pathogenesis

Molecular basis of bacterial outer membrane permeability revisited

Maintenance of C. elegans

Pseudomonas aeruginosa population structure revisited.

Parasin I, an antimicrobial peptide derived from histone H2A in the catfish, Parasilurus asotus.

P304

e01379-14

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

958051

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/MBIO.01379-14

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Paul Pirnay

Victor Van Puyenbroeck

P577

2014-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263711960

http://www.w3.org/2001/XMLSchema#string

P698

24987094

http://www.w3.org/2001/XMLSchema#string

P921

Gram-negative bacteria

multiple drug resistance

P932

4161244

http://www.w3.org/2001/XMLSchema#string